In vitro activity of caspofungin against planktonic and sessile Candida sp. cells

Polish Journal of Microbiology

Volumn 55, Issue 2, 2006, Pages 133-137

  Serefko, Anna ^a   Chudzik, Beata ^a   Malm, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Adhesion; Biofilm; Biomaterials; Candida sp.; Caspofungin

Indexed keywords

CASPOFUNGIN;

ARTICLE; BALLOON CATHETER; BIOFILM; CANDIDA; CONTROLLED STUDY; DEVICE INFECTION; DRUG ACTIVITY; DRUG EFFECT; DRUG SENSITIVITY; FUNGAL CELL; FUNGAL COLONIZATION; HOSPITAL INFECTION; IN VITRO STUDY; MICROBIAL ADHESION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; RHINOPHARYNGITIS; YEAST;

ANTIFUNGAL AGENTS; BIOCOMPATIBLE MATERIALS; BIOFILMS; CANDIDA; CROSS INFECTION; ECHINOCANDINS; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; SILICONE ELASTOMERS;

CANDIDA;

EID: 33745932306     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bachmann S.P., K. Vande Walle, G. Ramage, T.F. Patterson, B.L. Wickes, J.R. Graybill and J.L. Lopez-Ribot. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46: 3591-3596.
2. Bartizal C. and F.C. Odds. 2003. Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus. Antimicrob. Agents Chemother. 47: 2100-2107.
3. Chandra J., D.M. Kuhn, P.K. Mukherjee, L.L. Hoyer, T. McCormick and M.A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 5385-5394.
4. Chryssanthou E. and M. Cuenca-Estrella. 2002. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. J. Clin. Microbiol. 40: 3841-3844.
5. Douglas L.J. 2002. Medical importance of biofilms in Candida infections. Rev. Iberoam. Micol. 19: 139-143.
6. Hawser S.P. and L.J. Douglas. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62: 915-921.
7. Jabra-Rizk M.A., W.A. Falkler and T.F. Meiller. 2004. Fungal biofilms and drug resistance. Emerg. Infect. Dis. 10: 14-19.
8. Kuhn D.M., T. George, J. Chandra, P.K. Mukherjee and M.A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46: 1773-1780.
9. Letscher-Bru V. and R. Herbrecht. 2003. Caspofungin: the first representative of anew antifungal class. J. Antimicrob. Chemother. 51: 513-521.
10. Levitz S.M. and D. Diamond. 1985. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J. Infect. Dis. 152: 938-944.
11. Lindahl M., A. Farias, T. Wadstrom and S. Hjerten. 1981. A new test based on "salting out" to measure relative surface hydrofobicity of bacterial cells. Biochem. Biophys. Acta 677: 471-476.
12. Ramage G., K. Vande Walle, S.P. Bachmann, B.L. Wickes and J.L. Lopez-Ribot. 2002. In vitropharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46: 3634-3636.
13. Stevens D.A., M. Espiritu and R. Parmar. 2004. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob. Agents Chemother. 48: 3407-3411.
14. Soustre J., M.H. Rodier, S. Imbert-Bouyer, G. Daniault and C. Imbert. 2004. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins. J. Antimicrob. Chemother. 53: 522-525.